Clinical Scorecard: Corneal Cross-Linking (CXL) in Specialty Contact Lens Practice

At a Glance

Key Highlights

• CXL is FDA-approved and considered standard of care since 2015 for keratoconus and ectatic diseases.
• Medical necessity criteria include documented progression via keratometry or refraction changes within 24 months.
• Contraindications include corneal scarring, severe ocular surface disease, prior herpetic infection, and insufficient corneal thickness.

Guideline-Based Recommendations

Diagnosis

• Confirm keratoconus diagnosis based on keratometry and corneal topography.
• Document progression defined as ≥1 D increase in steepest keratometry or manifest cylinder, or ≥0.50 D increase in spherical equivalent within 24 months.
• Ensure corrected distance visual acuity worse than 20/20 with proper correction.

Management

• Refer patients meeting criteria for CXL to qualified surgeons or perform CXL if trained.
• Verify corneal thickness is ≥300 microns (some guidelines recommend ≥400 microns) before procedure.
• Rule out contraindications such as corneal scarring, severe ocular surface disease, prior or current herpetic infection.

Monitoring & Follow-up

• Monitor keratometry and refraction changes over time to assess progression.
• Maintain documentation to support medical necessity for insurance coverage.

Risks

• Potential for delayed epithelial healing especially in patients with prior chemical injury or systemic disease.
• Contraindications include corneal scarring and active ocular infections.

Patient & Prescribing Data

Patients with progressive keratoconus or ectasia aged 14 years and older

Insurance coverage may vary; patients should verify benefits due to possible coverage gaps despite medical necessity.

Clinical Best Practices

• Establish firm diagnosis with topography before referral.
• Provide detailed progression documentation to surgeons to support insurance approval.
• Educate patients about potential insurance coverage limitations and encourage verification with their payors.

References

• Global consensus on keratoconus and ectactic diseases (Gomes et al, 2015)
• Glaukos iLink FDA-approved corneal cross-linking
• US Government Publishing Office: Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary
• Anthem Clinical UM Guideline: Corneal Collagen Cross-Linking
• United Healthcare Corneal Collagen Cross-Linking Policy
• American Academy of Ophthalmology EyeWiki: Corneal Cross-Linking